Xeljanz FAQs

Frequently Asked Questions About Xeljanz

Jed Dietrich, Esq. and His Team of Dedicated, Tenacious, and Trustworthy Attorneys at the Dietrich Law Firm P.C. Persuasively Litigate to Obtain Noteworthy Results for Victims Who Have Suffered Severe Side Effects After Taking Xeljanz in Buffalo, New York; Niagara Falls, New York; Rochester, New York; Throughout New York State and Beyond.

---

Suppose you, or someone you care about, has been prescribed Xeljanz and developed blood clots or cancer; you may be entitled to pursue monetary compensation. Jed Dietrich, Esq. understands your feelings of anger, anxiety, and frustration. The Dietrich Law Firm P.C.’s veteran team of personal injury attorneys have fought for thousands of victims whose lives were turned upside down because of another’s negligence, including various cases involving dangerous and defective drugs. The Dietrich Law Firm P.C.’s honorable devotion to surpassing your expectations and delivering unbeatable results is what sets us apart from the competition.

For more than 20 years, Jed Dietrich, Esq. has amassed over $175 million in jury verdicts and settlements for his clients who were critically injured in Buffalo, New York, throughout New York State, and beyond. Our remarkable team will take prompt measures to file a lawsuit and preserve your legal right to compensation. The Dietrich Law Firm P.C.’s elite and highly experienced Xeljanz blood clot attorneys strive to obtain the best possible outcome for victims suffering from pulmonary embolisms and other damages. Below, our leading team has compiled a list of frequently asked questions and answers regarding Xeljanz injury claims. Please contact us today at 716-839-3939 or by filling out our online consultation form for your free, no-obligation case evaluation.

FAQs Concerning Xeljanz Lawsuits

Some of the most frequently asked questions concerning Xeljanz and heart injuries include:

1. What is Xeljanz used for? The pharmaceutical giant Pfizer Inc. manufactures and markets Xeljanz. Xeljanz (tofacitinib) is a medication prescribed to treat adults suffering from moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Since being approved by the United States Food and Drug Administration (FDA) in 2012, Xeljanz has quickly gained popularity, especially among patients who do not respond to other arthritis drugs. Xeljanz is the first and only oral Janus kinase (JAK) inhibitor that works by suppressing responses from the patient’s immune system.

2. What is rheumatoid arthritis? According to the Centers for Disease Control and Prevention (CDC), rheumatoid arthritis (RA) is an autoimmune and inflammatory disease that causes the immune system to mistakenly attack healthy cells. Over 54 million adults and approximately 300,000 children have arthritis or other similar rheumatic diseases. Rheumatoid arthritis predominately attacks joints in the knees, hands, and wrists. The disease causes the lining of the joint to become inflamed, leading to damage of the joint tissue. This tissue damage can cause patients to suffer from lack of balance, chronic pain, and even deformity.

3. What are the potential health risks of Xeljanz? While earlier clinical trials demonstrated that patients were vulnerable to adverse health effects at only high doses, the Food and Drug Administration’s recent analysis uncovered severe side effects even at lower doses. Xeljanz can cause serious health complications, such as blood clots, pulmonary embolism, deep vein thrombosis, kidney failure, liver damage, liver failure, upper respiratory tract infection, lung failure, sepsis, heart attacks, strokes, prostate cancer, breast cancer, lung cancer, pancreatic cancer, melanoma, and even death.

4. Has the U.S. Food and Drug Administration taken any action against Pfizer? The Food and Drug Administration ordered revisions to Xeljanz’s Boxed Warning, the agency’s strictest warning, to include information regarding the risks of cancer, serious heart-related events, blood clots, and death. Additionally, to ensure that the benefits of the drug outweigh the risks in users, the agency has limited all approved uses to patients who have been unresponsive or cannot tolerate one or more tumor necrosis factor (TNF) blockers. While a future recall may be imminent, as of now, Xeljanz has not been recalled.

5. Are there any common signs that I should watch out for? If you are currently taking Xeljanz, we highly recommend consulting with your doctor. Tell your doctor that you are concerned about the drug’s adverse effects.

6. Did Pfizer know that Xeljanz was dangerous? There is evidence confirming Pfizer’s knowledge of the risks related to Xeljanz. In 2013, the European Medicines Agency refused to approve the 10-milligram dosage of Xeljanz because studies found it was unsafe. However, Pfizer never disclosed this vital information to American patients and intentionally failed to provide uniform cross-country labeling.

7. What damages can I recover for my Xeljanz claim? The Dietrich Law Firm P.C.’s battle-tested attorneys are determined, disciplined, and dedicated to obtaining the highest possible monetary compensation for clients who have suffered health problems after taking Xeljanz. Victims diagnosed with cancer or diseases may be entitled to pursue compensation for injuries through a product liability claim.

8. Is there a time limit when I have to file my Xeljanz lawsuit? Under New York State law, there is a statute of limitations for dangerous and defective medication claims. Accordingly, victims diagnosed with cancer or other health issues caused by Xeljanz only have a limited time from the date they were diagnosed to file a claim against Pfizer. Failing to file a lawsuit within the applicable statute of limitations can block your right to recover compensation for damages.

Devastating stories of victims developing heart-related issues, cancer, and other chronic medical conditions after taking Xeljanz have inspired Jed Dietrich, Esq., to provide the highest level of personal injury service to his clients in Buffalo, New York, throughout New York State, and beyond. The Dietrich Law Firm P.C.’s superior attorneys have the expertise and knowledge to obtain the best possible result for all your injuries. If you have any further questions about pursuing a lawsuit against Pfizer, please feel free to contact us. You can get in touch with our seasoned team by calling 716-839-3939. The Dietrich Law Firm P.C.’s highly experienced and top rated Xeljanz injury lawyers are available 24 hours per day and 7 days per week.

---

Call the Dietrich Law Firm P.C. immediately at 716-839-3939 so that our aggressive, tenacious and hardworking personal injury lawyers can fight to obtain the best result for your personal injury claim in Buffalo, New York. We are available 24 hours a day, 7 days a week, and there is never a fee until we WIN for you!

---